stella
beta
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma — Stella
Recruiting
Back to Glioblastoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Lenox Hill Brain Tumor Center, New York, New York
View full record on ClinicalTrials.gov